Daratumumab approved as multiple myeloma treatment

Are you looking for a
specific medicine?
The FDA approval of a promising new drug is offering new hope to multiple myeloma patients who have already been through various treatments. Daratumumab has been approved in the USA for the treatment of patients with multiple myeloma [1] who have received at least three prior lines of therapy including a proteasome inhibitor (PI) and an immunomodulatory agent, or who are double-refractory to a PI and an immunomodulatory agent [2].


Daratumumab for Multiple Myeloma

This means that multiple myeloma patients who have received at least three separate treatments have a new medicine in their treatment options.  

Multiple myeloma is a form of blood cancer that occurs in infection-fighting plasma cells (a type of white blood cell) found in the bone marrow. These cancerous cells multiply, producing an abnormal protein and pushing out other healthy blood cells from the bone marrow [1]. Daratumumab is a monoclonal antibody (it is cloned from a single parent cell) that works by helping certain cells in the immune system attack the cancer cells [1].

Patients living outside of the USA can order daratumumab on LoveSteve.com when a doctor’s prescription is provided.

For further reading, we recommend this article from Myeloma Survival.

More information about the safety and efficacy of daratumumab can be found at the following links:


DISCLAIMER: Nothing can replace the care of your clinician or doctor. Please do not make changes to your treatment or schedules without first consulting your healthcare providers. This article is not intended to diagnose or treat illness.



Related Articles

Telling your child you have cancer

Suggestions from cancer survivors and their children

Dealing with a Diagnosis

Online counsellor Nicole Hind shares how to help our brains and bodies deal with a diagnosis

Registered with the Dutch Ministry of Health as an independent intermediary, Registration number 6730 BEM
Registered as a USA Delaware LLC.

Share our website

Follow us

DISCLAIMER: The Services of TheSocialMedwork do not replace a physician-patient relationship and are not intended as medical advice. TheSocialMedwork provides patients and physicians with existing treatment options abroad and creates access to these options after the patient and physician have made a professional decision. Privacy Policy / Terms and Conditions
Our service uses cookies.